BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//WA Innovation Calendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://wainnovationcalendar.com.au
X-WR-CALDESC:Events for WA Innovation Calendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240820T170000
DTEND;TZID=Australia/Perth:20240820T193000
DTSTAMP:20260505T002538
CREATED:20240702T011925Z
LAST-MODIFIED:20260407T033125Z
UID:10002314-1724173200-1724182200@wainnovationcalendar.com.au
SUMMARY:WA MTP Sector Spotlight: What’s Next for Biotech?
DESCRIPTION:This is a unique opportunity to hear from Leighton\, an esteemed Silicon Valley-based serial entrepreneur and venture investor\, and network with the sector. \nDelivered in partnership with RSM and Brandon Capital\, this event has been scheduled to align with a Brandon BioCatalyst Investment Review Committee meeting – we are pleased to welcome commercialisation professionals from leading MRIs and Health Departments across Australia and New Zealand to the event and invite them to network with the WA sector. \nDetails: \nTuesday 20 August \nRSM Australia \nLevel 32 Exchange Tower \n2 The Esplanade\, Perth \nAbout the Speaker: \nLeighton Read MD is a Silicon Valley-based serial entrepreneur and venture investor. A medical doctor by training\, Leighton’s diverse career includes diverse roles and multiple notable ventures. \nPrior to joining Brandon Capital\, Leighton was a Founder and served as Managing Director and President of the Pharma Division at Affymax NV (acquired by Glaxo in 1995 for $533 million). He was also the founding investor\, Chairman and CEO of Aviron (acquired by MedImmune in 2001 for $1.5 billion) and Avidia (acquired by Amgen in 2006 for $380 million). \nLeighton completed internal medicine training at Duke and the Peter Bent Brigham Hospital\, where he held appointments at Harvard Medical School and School of Public Health. He is currently Non-Executive Chairman of Global Kinetics\, and a director of Allay Therapeutics and Glyscend Therapeutics.
URL:https://wainnovationcalendar.com.au/event/wa-mtp-sector-spotlight-whats-next-for-biotech/
LOCATION:32/2 The Esplanade\, 3/2 The Esplanade\, Perth\, WA\, 6000\, Australia
CATEGORIES:Seminar / Panel Discussion / Conversation
END:VEVENT
END:VCALENDAR